Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
20.20
+0.47 (2.38%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Employees
Fulgent Genetics had 1,315 employees as of December 31, 2025. The number of employees increased by 2 or 0.15% compared to the previous year.
Employees
1,315
Change (1Y)
2
Growth (1Y)
0.15%
Revenue / Employee
$246,336
Profits / Employee
-$64,169
Market Cap
555.81M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,315 | 2 | 0.15% |
| Dec 31, 2024 | 1,313 | 129 | 10.90% |
| Dec 31, 2023 | 1,184 | 172 | 17.00% |
| Dec 31, 2022 | 1,012 | 367 | 56.90% |
| Dec 31, 2021 | 645 | 165 | 34.38% |
| Jun 30, 2021 | 626 | 153 | 32.35% |
| Mar 31, 2021 | 700 | 561 | 403.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Castle Biosciences | 1,002 |
| Burning Rock Biotech | 667 |
| Freenome | 381 |
| Biodesix | 334 |
| Personalis | 260 |
FLGT News
- 5 weeks ago - Fulgent Genetics price target raised to $19 from $15 at Piper Sandler - TheFly
- 5 weeks ago - Fulgent Genetics reports Q2 adjusted EPS (58c), two estimates (44c) - TheFly
- 5 weeks ago - Fulgent Genetics cuts FY26 adjusted EPS view to ($2.35)-($2.22) from ($1.59) - TheFly
- 5 weeks ago - Fulgent Genetics Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Fulgent Genetics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Fulgent Genetics Slides: Q2 2026 - Filings
- 5 weeks ago - Fulgent Genetics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Fulgent Reports Second Quarter 2026 Financial Results - Business Wire